. 2001 Feb;92(2):126-7.

[Integrated (surgical and hormonal) treatment of advanced prostatic carcinoma. Comment on the study and the interview with Edward M. Messing]

[Article in Italian]

Affiliations

[Article in Italian]

T Prayer Galetti. Recenti Prog Med. 2001 Feb.

. 2001 Feb;92(2):126-7.

No abstract available

Similar articles

[Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla].
Bolla M. Bolla M. Recenti Prog Med. 2001 Feb;92(2):128-9. Recenti Prog Med. 2001. PMID: 11294104 Italian. No abstract available.
[Adjuvant or therapeutic androgen suppression in locoregional advanced prostatic carcinoma (RTOG 85-31)].
Hinkelbein W. Hinkelbein W. Strahlenther Onkol. 1998 Jul;174(7):385-6. doi: 10.1007/BF03038357. Strahlenther Onkol. 1998. PMID: 9689964 Clinical Trial. German. No abstract available.
Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
Di Silverio F, Serio M, Costantini A. Di Silverio F, et al. J Chemother. 1989 Jul;1(4 Suppl):1231-4. J Chemother. 1989. PMID: 16312846 No abstract available.
Evaluating the use of early hormonal therapy in patients with localised or locally advanced prostate cancer.
Kaisary AV. Kaisary AV. Prostate Cancer Prostatic Dis. 2005;8(2):140-51. doi: 10.1038/sj.pcan.4500800. Prostate Cancer Prostatic Dis. 2005. PMID: 15852051 Review.
[Reevaluation of MAB therapy and progress of endocrine therapy].
Klotz L, Payne H, Gillatt D, Keane T, Morris C, Akaza H, Hirao, Akakura K, Fukagai T. Klotz L, et al. Gan To Kagaku Ryoho. 2005 May;32(5):705-28. Gan To Kagaku Ryoho. 2005. PMID: 15934164 Review. Japanese. No abstract available.